5-(2,6-dioxopiperidin-3-yl)-4,6-difluoro-1H-indole-2-carboxylic acid Quantity:100 mg Macrocyclic Dual-Locked “Turn-On” Drug for

Macrocyclic Dual-Locked “Turn-On” Drug for Selective and Traceless Release in Cancer Cells Angew

Radical S-Adenosylmethionine Sulfurtransferase MybB Catalyzed Formation of the 4-Thiazolidinone Core in Mycobacidin Represents an Intersection between Primary and Secondary Metabolism J

T Cell Engagers

Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs Bioconjugate Chem

Fab-PEG-Fab as a Potential Antibody Mimetic

5-(2,6-dioxopiperidin-3-yl)-4,6-difluoro-1H-indole-2-carboxylic acid Quantity:100 mg Macrocyclic Dual-Locked “Turn-On” Drug for